ClinicalTrials.gg
Drug

Vildagliptin clinical trials

Also written Galvus, LAF237 and LAF237A.

studies test it
153
open now
5
in phase 3
75
first study started
2003

How each study uses Vildagliptin is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the Vildagliptin studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
Not in FDA's approval records
European Union
25 Sept 2007 · Galvus · EMEA/H/C/000771 (EMA)

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Vildagliptin
113
Vildagliptin 50 MG
10
Vildagliptin (LAF237)
4
Vildagliptin (Galvus)
3
Vildagliptin 50 mg Oral Tablet
2

Brand

Galvus
24
Galvus 50 mg
1

Development codes

LAF237
7
LAF237A
2

In one entry with another drug

Given together, or one or the other

Vildagliptin + Metformin
4

Studies by the year they started

153 studies that test it; most in 2004 (17)

Studies that test Vildagliptin, by start year
YearStudies
20031
200417
200517
200616
20074
200810
20097
201016
201111
201211
201310
20147
20151
20163
20172
20184
20193
20202
20211
20221
20235
20241
20252
20261

Who runs them

Industry 99 · Other 54

Novartis Pharmaceuticals (48) · Novartis (43) · Lund University (4) · Damanhour University (3) · Merck Sharp & Dohme LLC (2) · University of Campania Luigi Vanvitelli (2) · Sadat City University (2) · Centre Hospitalier Universitaire de Besancon (1)

Often tested with

Tested in the same studies.

Metformin (15) · Sitagliptin (7) · Dapagliflozin (4) · Glimepiride (4) · Empagliflozin (3) · Pioglitazone (3) · Saxagliptin (3) · Canagliflozin (2)

Related medicines

As reviewed, each with the page that says it.

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Reaching primary completion within a year · 2, 1 in phase 3

Studies that test Vildagliptin, phase 3 first.

Studies

Open first, then newest update. How each study uses Vildagliptin is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 153

See all 153 studies that test Vildagliptin →

Given beside what is tested · 2 — Vildagliptin is usual care or a partner of the new treatment
As the comparator · 9 — what is tested is compared with Vildagliptin

Codes

What other systems call Vildagliptin · ClinicalTrials.gg INT006771

  • MeSH (NLM) D000077597VildagliptinConfirmed ClinicalTrials.gov, NLM, Wikidata
  • UNII (FDA) I6B4B2U96PVILDAGLIPTINConfirmed FDA, NLM, Wikidata
  • RxNorm 596554Confirmed FDA, Wikidata
  • Wikidata Q421042vildagliptinConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C66653VildagliptinOne source FDA
  • DrugBank DB04876One source Wikidata

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.